Investors

Creating long-term value
Creating long-term value

News & Events

Date Event Description
17 Apr 2014

Q1 Results 2014

Webcast with financial results for the first 3 months of 2014

08 May 2014

AGM

The Annual General Meeting of Shareholders

22 July 2014

HY Results 2014

Webcast with financial results for the first 6 months of 2014

21 Oct 2014

Q3 Results 2014

Webcast with financial results for the first 9 months of 2014

Learn more about the events

key information

On 11 February 2014 Actelion announced the Full Year 2013 financial results. These results were accompanied by the publication of the company's Annual Report.

 
Learn more
 

AGM

AGM to be held on 08 May 2014

Annual General Meeting 2014

The Annual General Meeting takes place on Thursday 08 May 2014.

AGM to be held on 18 April 2013

Annual General Meeting 2014

The Annual General Meeting takes place on Thursday 08 May 2014.

Financial Information

In CHF million

(except for per share data)

Results

FY 2013

Results

FY 2012

% Variance
in CHF

% Variance
at CER

Product sales

1,784

1,722

4

6

Core operating expenses

1,165

1,185

(2)

1

Core earnings

619

537

15

20

Core EPS (fully diluted)

4.41

3.81

16

20

Net US GAAP EPS (fully diluted)

3.92

2.57

53

60

No. of shares in calculation

115.377

118.120

-

-

Contact

Investor Relations
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil
Switzerland
Phone:+41 61 565 62 62
Fax:+41 61 565 65 07